Measures of biological age based on blood DNA methylation, referred to as age acceleration (AA), have been developed. We examined whether AA was associated with health risk factors and overall and cause-specific mortality. At baseline (1990)(1991)(1992)(1993)(1994), blood samples were drawn from 2,818 participants in the Melbourne Collaborative Cohort Study (Melbourne, Victoria, Australia). DNA methylation was determined using the Infinium HumanMethylation450 BeadChip array (Illumina Inc., San Diego, California). Mixed-effects models were used to examine the association of AA with health risk factors. Cox models were used to assess the association of AA with mortality. A total of 831 deaths were observed during a median 10.7 years of follow-up. Associations of AA were observed with male sex, Greek nationality (country of birth), smoking, obesity, diabetes, lower education, and meat intake. AA measures were associated with increased mortality, and this was only partly accounted for by known determinants of health (hazard ratios were attenuated by 20%-40%). Weak evidence of heterogeneity in the association was observed by sex (P = 0.06) and cause of death (P = 0.07) but not by other factors. DNA-methylation-based AA measures are associated with several major health risk factors, but these do not fully explain the association between AA and mortality. Future research should investigate what genetic and environmental factors determine AA.
Aging is associated with profound changes to DNA methylation. Globally, a decrease in methylation levels with age is observed, as well as a tendency for both hypo-and hypermethylated CpG sites to lose their initial epigenetic state and become hemimethylated (1) (2) (3) . These changes are thought to play a role in the risk of disease (4) (5) (6) (7) . Recently, the concept of an "epigenetic clock" has emerged as a marker of biological aging (8) . Several studies have attempted to quantify the age of the methylome using regularized regression methods to obtain a restricted set of DNA methylation measures predicting age (9) (10) (11) (12) (13) . Two of these models have received more attention, as they predict chronological age most accurately (9, 11) . Although the accurate prediction of chronological age is of interest to forensic scientists (14) , the difference between predicted age (linear combination of age-associated methylation measures) and chronological age is also thought to represent an estimate of "age acceleration" (AA) and has been interpreted in epidemiologic studies as a marker of biological aging.
Several studies have investigated the association between AA in blood and all-cause mortality. In one study, Marioni et al. (15) pooled data on 4 cohorts from the United Kingdom and the United States, comprising 808 deaths, and reported 16% and 9% increased mortality per 5-year increase in AA based on the Hannum et al. (9) and Horvath (11) predictors, respectively, after adjusting for several health risk factors. Similar findings were reported from an elderly German cohort (1,863 participants; 602 deaths) (16) , with mortality increases of 10% and 23% per 5-year increment of AA according to the Hannum and Horvath predictors, respectively. In a Danish cohort study of 86 twin pairs, among which 55 deaths occurred, Christiansen et al. (17) reported a 35% increased risk of death per 5-year AA increment based on both Hannum's and Horvath's predictors. A recent pooled analysis by Chen et al. (18) showed mortality risks increased by 14% and 8%, respectively. Outcomes other than mortality have been investigated, including lung cancer (19) and Alzheimer's disease (20) . Distinct AA profiles have been observed in the blood of centenarians and their offspring (21, 22) .
If AA reflects biological age, it seems reasonable to expect that it is influenced by known risk factors for poor health (8) . AA has been shown to be associated with obesity, most notably in liver tissue (11, 23) . Cross-sectional associations with physical and cognitive ability (24) , menopause (25) , human immunodeficiency virus infection (26, 27) , lifetime stress (28) , posttraumatic stress disorder (29) , and frailty in the elderly (30) have been reported.
Our aim was to add to the growing literature on AA and health by 1) assessing associations between AA and known health risk factors, as well as all-cause and cause-specific mortality, and 2) examining the extent to which various lifestyle factors contribute to the relationship between AA and mortality, using a large cohort of middle-aged and older adults.
METHODS

Study sample
We used data from studies nested within the Melbourne Collaborative Cohort Study (Melbourne, Victoria, Australia), a prospective cohort study of 41,514 healthy adult volunteers (24,469 women) aged 27-76 years (99.3% were aged 40-69 years) at baseline between 1990 and 1994 (31) . DNA samples used for the present analysis were extracted from peripheral blood drawn at the time of recruitment (1990) (1991) (1992) (1993) (1994) . For the majority (70%) of participants, the DNA source was dried blood spots collected onto Guthrie Card Diagnostic Cellulose filter paper (Whatman plc, Kent, United Kingdom) and stored in airtight containers at room temperature. The other sources of DNA were peripheral blood mononuclear cells and buffy coats stored at −80°C for 28% and 2% participants, respectively.
The study sample comprised Melbourne Collaborative Cohort Study participants selected as controls in nested casecontrol studies of breast, colorectal, kidney, lung, prostate, or urothelial cancer or mature B-cell malignancies (32) (33) (34) (35) . Controls had been individually matched to cases on age (they had to be free of cancer at an age within 1 year of the age at diagnosis of the corresponding case), sex, country of birth, and blood DNA source (dried blood spot, peripheral blood mononuclear cells, or buffy coat). For all but the colorectal cancer study, controls were matched to cases on year of birth. For the lung cancer study, controls were matched on smoking status at the time of blood collection.
Vital status up to August 31, 2015, was ascertained through record linkage to the Victorian Registry of Births, Deaths and Marriages (via the Victorian Cancer Registry) and the National Death Index (via the Australian Institute of Health and Welfare). Cause of death, based on the underlying cause of death from the death certificate, was known for deaths occurring up to December 31, 2013 .
Methods relating to DNA extraction and bisulfite conversion and DNA methylation data processing are described in the Web Appendix (available at https://academic.oup.com/aje).
Methylation age and AA
All of the CpGs used to compute Hannum and Horvath methylation ages were available in our study after quality control. Hannum methylation age was computed using the linear combination of methylation measures at 71 age-associated CpGs (15). Horvath methylation age was calculated on the basis of methylation measures at 353 CpGs using the online calculator (11) . We considered the most recent measures of AA (18, 36) 
Statistical analysis
Correlations between AA measures were assessed using Spearman correlation coefficients. To evaluate the accuracy of the Horvath and Hannum age predictors, we computed the median absolute value of each AA measure. The reliability of methylation measures for CpG sites included in the predictors was examined using intraclass correlation coefficients computed using mixed models and based on 134 technical replicate pairs as described in previous publications (37, 38) . Missing covariate data (<1% for any individual covariate) were handled using multiple imputation (39) , with the R package mice (R Foundation for Statistical Computing, Vienna, Austria) (40) .
Health risk factors associated with AA. We used linear regression models to examine the association between AA measures and known risk factors for disease, all assessed at baseline. Factors considered and adjusted for were: age; sex; country of birth (Australia/New Zealand, United Kingdom/Malta, Italy, or Greece); smoking (never smoker, former smoker who had quit ≤15 years prior, former smoker who had quit >15 years prior, current smoker of ≤20 cigarettes/day, or current smoker of >20 cigarettes/day); body mass index (BMI; calculated as weight (kg)/height (m) 2 and categorized as <25, 25-29.9, 30-34.9, or ≥35); height (cm; continuous); alcohol intake (none, 1-39 g/ day (males) or 1-19 g/day (females), 40-59 g/day (males) or 20-39 g/day (females), or ≥60 g/day (males) or ≥40 g/day (females)); Alternate Healthy Eating Index 2010 score (to reflect overall diet quality) (41); a physical activity score ranging from 1 to 4 and reflecting metabolic equivalents, as described in previous work (42) ; socioeconomic status (a score from 1 to 10 representing the relative socioeconomic disadvantage of the participant's area of residence (43)); and education (a score from 1 to 8; 1 = primary school only and 8 = tertiary university degree or more). We also considered the following clinical variables: history of cardiovascular disease (stroke, angina, or heart attack), hypertension, diabetes, asthma, kidney stones, gallstones, arthritis, and resting heart rate (measured with the Dinamap 1846SX automated blood pressure monitor (Critikon, Tampa, Florida)). Each of these clinical factors was added individually to the previous model. Results of all models were additionally adjusted for sample type (dried blood spot, peripheral blood mononuclear cells, or buffy coat), study, and the plate on which the sample was processed (the latter 2 variables being fitted as random effects and hereafter referred to as batch effects). More detailed analyses were conducted using additional variables relating to diet, clinical factors, smoking, alcohol intake, anthropometric factors, psychological well-being, and blood measures (Web Table 5 ).
We used the same models to assess the associations between demographic, lifestyle, and anthropometric variables and each individual CpG site included in the Hannum and Horvath predictors. In these models, smoking, BMI, and alcohol intake were modeled as continuous variables.
AA and mortality. We used Cox models to estimate hazard ratios for the association between AA measures and mortality. Age was used as the time scale (44) , and participants were considered to be at risk from their index date (the date on which they reached the age at which their matched case in the corresponding nested case-control study was diagnosed with cancer) onward in order to avoid immortal time bias, as they had to be alive at this date. For each AA measure, the proportional hazards assumption was assessed by visual inspection of Schoenfeld residuals (45) . Separate models were fitted for all-cause, cancer, cardiovascular disease, and other-cause mortality. Personyears of follow-up were calculated from the index date to the date of death, and participants were censored at the date of departure from Australia or the end of follow-up (August 31, 2015, for all-cause death and December 31, 2013, for causespecific death), whichever came first. In cause-specific analyses, deaths from other causes were censored, which is a way to model the cause-specific hazard function, appropriately taking the competing risk of other-cause death into account (46) . For comparability with previous publications, hazard ratio estimates were calculated for a 5-year increase in AA measures (15) (16) (17) . For overall and cause-specific mortality analyses, 3 models were fitted in order to examine the robustness of the association between AA measures and mortality: In model 0 (unadjusted), results were adjusted for sample type and batch effects; in model 1 (minimally adjusted), we added age at blood draw, sex, and country of birth to model 0; in model 2, we added anthropometric measures, lifestyle factors, and socioeconomic variables (BMI, height, smoking, alcohol intake, diet quality, physical activity, socioeconomic status, and education) to model 1; and in model 3, we added clinical variables to model 2. Batch effects were fitted as fixed effects, and similar results were obtained when using mixed-effects Cox models (47) .
To investigate whether AA measures were more strongly associated with specific causes of death, heterogeneity in the associations between AA and mortality by cause of death was tested using the data duplication method (48) . Interactions between AA measures and each of sex, country of birth, smoking, and BMI were examined by adding interaction terms to the model and applying a likelihood ratio test. Analyses for AA were repeated with adjustment for cell composition (as defined by the Houseman algorithm (49)).
Ethics
Study participants provided informed consent in accordance with the Declaration of Helsinki. The study was approved by Cancer Council Victoria's Human Research Ethics Committee and performed in accordance with the institution's ethical guidelines.
RESULTS
The correlation between the Hannum and Horvath age predictors was ρ = 0.75, and their correlation with chronological age was high (ρ = 0.76 and ρ = 0.73, respectively) ( Table 1) . The median AA (IEAA) was, in absolute terms, 3.9 years and 4.2 years for the Hannum and Horvath predictors, respectively ( Figure 1 , panels A and B, respectively). The correlation between IEAA measures was 0.56 ( Table 1 ). The reliability of methylation measures was high for CpG sites included in Hannum's age predictor (median intraclass correlation coefficient, 0.60; interquartile range, 0.53-0.68) and more variable for those included in Horvath's predictor (median intraclass correlation coefficient, 0.48; interquartile range, 0.22-0.61) (Web Table 8 and Web Figure 1 ).
A total of 2,818 participants were included in the analysis of health risk factors. Higher AAs were observed in males compared with females (IEAA-Hannum: β = 1.37 years, P < 0.001; IEAA-Horvath: β = 1.23 years, P = 0.005); in Greek participants compared with those born in Australia/ New-Zealand (IEAA-Horvath: β = 1.29 years, P = 0.01); in current and former smokers compared with never smokers (IEAA-Hannum: current smoker of ≤20 cigarettes/day-β = 2.12 years, P < 0.001; current smoker of >20 cigarettes/day-β = 1.26 years, P = 0.01), and in overweight (BMI ≥25) and obese (BMI ≥30) persons compared with lean individuals (BMI <25) (IEAA-Hannum: BMI 25-29.9-β = 0.69 years, P = 0.01; BMI 30-34.9-β = 1.24 years, P < 0.001; BMI ≥35-β = 1.70 years, P = 0.01). Higher education was associated with lower AA (AA-Horvath: per 1-unit increment in education score, β = −0.16 years, P = 0.04 (Web Table 1) ). Most reported comorbid conditions were not associated with AA measures, except for diabetes (IEAA-Horvath: β = 1.46 years, P = 0.04) and prior history of gallstones (IEAA-Horvath: β = 1 year, P = 0.03) ( Table 2 ). Intake of meat was associated with increased AA (IEAA-Horvath: P = 0.01), and intake of fruits, but not vegetables, was associated with decreased AA (IEAAHannum: P = 0.03 and P = 0.91, respectively). Most body composition measures were associated with increased AA (Web Table 5 ).
Several individual CpG sites included in the Hannum and Horvath predictors were associated with demographic, lifestyle, and anthropometric variables (after correction for multiple testing for 424 tests, P < 1.1 × 10
−4
). Most of them were strongly associated with age, and associations were also observed with sex (74 CpGs), smoking (9 CpGs), and alcohol intake (6 CpGs) (Web Table 9 ).
A total of 831 deaths were observed during follow-up (median, 10.7 years), including 692 with information on cause of death (follow-up until December 31, 2013) . Unadjusted analyses (model 0) showed associations of AA measures with all-cause mortality (IEAA-Hannum: per 5-year increment in AA, hazard ratio (HR) = 1.08, 95% confidence interval (CI): 1.02, 1.14; findings were similar for other AA measures) ( Table 3) . After adjustment for age, sex, and country of birth (model 1), the associations for IEAA were attenuated by up to 7% (IEAAHannum: 7%; IEAA-Horvath: 0%) ( Table 3) . After adjustment for lifestyle and anthropometric and socioeconomic variables (model 2), hazard ratios were attenuated by a further 18%-37% (IEAA-Hannum: 37%; IEAA-Horvath: 18%) but not further after adjustment for reported comorbidity (model 3). In total, the association of AA with overall mortality was attenuated by 18%-45% after adjustment for known health risk factors; the remaining association was 5% increased mortality per 5-year AA increment for all AA measures. AA was more strongly associated with cancer-related death (n = 240) than with other causes of death (IEAA-Hannum: HR = 1.12 (95% CI: 1.02, 1.24); IEAA-Horvath: HR = 1.11 (95% CI: 1.01, 1.21)) (Table 4) , with weak evidence of heterogeneity by cause of death (P-heterogeneity = 0.07 and P-heterogeneity = 0.14, respectively).
The estimated associations of IEAA measures with overall mortality appeared stronger for men than for women (IEAAHannum: men-HR = 1.08 (95% CI: 1.01, 1.15); women-HR = 0.97 (95% CI: 0.88, 1.07) (P-heterogeneity = 0.06); IEAA-Horvath: men-HR = 1.09 (95% CI: 1.02, 1.16); women-HR = 0.99 (95% CI: 0.91, 1.09) (P-heterogeneity = 0.11)). No evidence of effect modification was found for smoking status, BMI, or country of birth (Table 5 ). When the analysis was restricted to participants for whom follow-up started less IEAA, years (41) . f Physical activity score reflected metabolic equivalents, as described in previous work (42) ; possible scores ranged from 1 to 4. g Education was an ordinal questionnaire variable with possible scores ranging from 1 to 8 (1 = primary school only and 8 = tertiary university degree or more). than 5 years after blood draw, the hazard ratio estimates were similar to those based on all participants.
Associations of health risk factors with AA measures and associations of AA measures with mortality were similar for other AA measures (Web Tables 2-4 , 6, and 7) and were generally stronger in analyses of AA adjusted for cell composition (Web Tables 6 and 7 ).
DISCUSSION
Our study adds to the evidence regarding the use of the epigenetic clock as a marker of biological age. We observed that male sex, Greek nationality (country of birth), smoking, BMI, and diabetes were strongly associated with AA. In addition, AA measures were associated with increased risk of mortality, and these associations, albeit small, were independent of known mortality risk factors, including a large number of demographic, lifestyle, and anthropometric variables, and medical conditions. This suggests that a substantial proportion of AA is due to unidentified factors, which may include early-life exposures, health-associated genetic variants, or other unmeasured environmental factors.
The main limitation of our analysis of health risk factors associated with AA was its cross-sectional nature. Future studies should investigate what factors may explain temporal changes in AA. Information on most variables was self-reported, which may have induced some measurement error. Although CpGs included in the age predictors had higher-than-average reliability, measurement error may also have decreased the accuracy of AA measures, particularly for the Horvath predictor. For the 2 ; <25, 25-29.9, 30-34.9, or ≥35), height (cm; continuous), smoking (never smoker; former smoker who quit ≤15 years prior; former smoker who quit >15 years prior; current smoker of ≤20 cigarettes/day; current smoker of >20 cigarettes/day), alcohol intake (1-19 g/day (females); 40-59 g/day (males) or 20-39 g/day (females); or ≥60 g/day (males) or ≥40 g/day (females)), diet quality (Alternate Healthy Eating Index 2010), physical activity (physical activity score ranging from 1 to 4 and reflecting metabolic equivalents (39)), socioeconomic status (score representing the relative socioeconomic disadvantage of the participant's area of residence, ranging from 1 to 10 (40)), and education (score ranging from 1 to 8, with 1 = primary school only and 8 = tertiary university degree or more).
d In model 3, the following clinical variables were added to model 2: history of asthma (yes/no), hypertension (yes/no), diabetes (yes/no), arthritis (yes/no), kidney stones (yes/no), gallstones (yes/no), or cardiovascular disease (yes/no) and resting heart rate (beats/minute; continuous). Abbreviations: CI, confidence interval; CVD, cardiovascular disease, HR, hazard ratio; IEAA, intrinsic epigenetic age acceleration. a Results were adjusted for age at blood draw, sex, country of birth (Australia/New Zealand, United Kingdom/Malta, Italy, or Greece), body mass index (weight (kg)/height (m) 2 ; <25, 25-29.9, 30-34.9, or ≥35), height (cm; continuous), smoking (never smoker; former smoker who quit ≤15 years prior; former smoker who quit >15 years prior; current smoker of ≤20 cigarettes/day; current smoker of >20 cigarettes/day), alcohol intake (1-19 g/day (females); 40-59 g/day (males) or 20-39 g/day (females); or ≥60 g/day (males) or ≥40 g/day (females)), diet quality (Alternate Healthy Eating Index 2010), physical activity (physical activity score ranging from 1 to 4 and reflecting metabolic equivalents (39)), socioeconomic status (score representing the relative socioeconomic disadvantage of the participant's area of residence, ranging from 1 to 10 (40)), education (score ranging from 1 to 8, with 1 = primary school only and 8 = tertiary university degree or more), sample type, and batch effects. mortality analysis, we left-truncated follow-up at the age at which the matching case was diagnosed, in order to account for the procedure used to select controls. This not only created a lag time between exposure assessment and the start of followup (implicitly, we assumed that AA remained constant between blood draw and the index date) but also substantially reduced the follow-up time and meant that controls were selected for not developing the cancer of interest in each individual nested casecontrol study. However, because each cancer was rare, any selection bias would have been minimal.
The Melbourne Collaborative Cohort Study has a low prevalence of unhealthy lifestyles (only 13% of participants were current smokers at baseline) and lower mortality rates than those in the general Australian population (50) . Thus, it may appear surprising that the estimates from both predictors were close to chronological age (mean chronological age = 59.0 years; mean Horvath-predicted age = 59.1 years; mean Hannum-predicted age = 59.0 years). Study participants were relatively old at the start of follow-up, which may have resulted in weaker observed associations (51) . However, when analyses were restricted to younger persons or to those with shorter lag times between blood sampling and the start of follow-up, the resulting hazard ratio estimates were not higher, indicating only a small influence of these limitations.
In the seminal study by Marioni et al. (15) , the adjusted (though not for BMI) mortality risk estimates varied by cohort, with hazard ratios ranging from 1.08 to 1.40 for AA-Hannum (with a pooled effect of HR = 1.16) and from 0.96 to 1.17 for AA-Horvath (with a pooled effect of HR = 1.09). In the study by Perna et al. (16) , a substantial proportion of included deaths Abbreviations: CI, confidence interval; het, heterogeneity; HR, hazard ratio; IEAA, intrinsic epigenetic age acceleration. a Results were adjusted for age at blood draw, sex, country of birth (Australia/New Zealand, United Kingdom/Malta, Italy, or Greece), body mass index (weight (kg)/height (m) 2 ; <25, 25-29.9, 30-34.9, or ≥35), height (cm; continuous), smoking (never smoker; former smoker who quit ≤15 years prior; former smoker who quit >15 years prior; current smoker of ≤20 cigarettes/day; current smoker of >20 cigarettes/day), alcohol intake (1-19 g/day (females); 40-59 g/day (males) or 20-39 g/day (females); or ≥60 g/day (males) or ≥40 g/day (females)), diet quality (Alternate Healthy Eating Index 2010), physical activity (physical activity score ranging from 1 to 4 and reflecting metabolic equivalents (39)), socioeconomic status (score representing the relative socioeconomic disadvantage of the participant's area of residence, ranging from 1 to 10 (40)), education (score ranging from 1 to 8, with 1 = primary school only and 8 = tertiary university degree or more), sample type, and batch effects. We did not correct our P values for multiple testing, which may have resulted in false-positive findings. Most of the observed associations between AA and health risk factors and mortality were in the expected direction. Additional studies will be required to confirm these associations. In a recent study examining lifestyle factors associated with AA, Quach et al. (52) found that higher BMI was associated with increased AA and that higher education and fish and alcohol consumption were associated with decreased AA. BMI was also associated with IEAA, as was poultry consumption (52) . Unlike this and other studies, we found a strong association of AA with smoking, which is consistent with the dramatic effects of smoking on health outcomes, but our findings did not replicate the previously reported association with consumption of poultry and fish. We also observed an association of AA and IEAA with education, which was not found in another large-scale study (53) .
Many molecular markers of biological aging have been proposed (54) , and future research should address how methylationdefined AA measures correlate with these. An analysis of the joint effects of methylation age and telomere length on mortality using 2 cohorts showed that AA and telomere length had independent effects on mortality (55) . Those analyses were limited by small sample sizes, and results were minimally adjusted (i.e., simply for age, sex, and estimated white blood cell composition). In an elderly German population, the comprehensive frailty measure that was evaluated appeared to be associated with AA-Horvath more than with telomere length (30) . There was no strong correlation of AA-Horvath with telomere length. Estimates of heritability computed by Marioni et al. (15) were around 0.40 for both AA-Hannum and AA-Horvath. In another study, Levine et al. (25) estimated heritability to be 0.65 using genome-wide complex trait analysis. Li et al. (56) used twins to examine the determinants of AA measures and concluded that although genetic factors played a role, the importance of shared environmental factors might have been overlooked, such that these heritability measures were overestimates. These studies, taken together, nevertheless suggest that genetic confounders of the AA-mortality association may exist, but we could not control for them in our analysis.
Hannum and Horvath measures of biological age require methylation measurement at a small number of CpG sites. The association of AA with health risk factors and with mortality suggests that it could be used to monitor an individual's health status, although this requires formal assessment. Given the sources of possible systematic bias and measurement error encountered with the assay we used (Infinium HumanMethylation450 BeadChip array (Illumina Inc., San Diego, California)) (38, 57) , one would expect that more accurate AA predictors could be derived using higher-resolution methylation measurement techniques (58) . Assays for obtaining AA estimates at lower cost are also being developed (59) . Tissues other than blood may offer useful alternative and potentially organ-or disease-specific AA measures (20, 23 ). An advantage of the Horvath AA measures is that they give an accurate prediction of age across multiple tissue types, allowing some generalizability of our findings to tissues other than blood (11) .
In conclusion, AA measures are associated with several established health risk factors and with mortality, independently of many of these health risk factors. In future studies, investigators should seek to identify genetic and additional environmental factors associated with AA and improve blood DNA methylation-based measures of biological age. 
